Mold-Tek Packaging Q2 FY26 Profit Increases 9.7% to ₹15.48 Crore; H1 Sales Grow 16.05%

Hyderabad, October 29, 2025 – Mold-Tek Packaging Ltd (NSE: MOLDTKPAC, BSE: 533080) posted a consolidated net profit of ₹15.48 crore in the quarter ended September 30, 2025, up 9.7% year-on-year from ₹14.11 crore in Q2 FY25. Revenue from operations went up 9.65% YoY to ₹209.76 crore, aided by continuous demand in the pharma, food and FMCG packaging segments. Sales volume rose 6.8% to 10,018 metric-tonnes during the quarter.

Half-Yearly Financial Performance

Mold-Tek’s revenue in the half-year ended H1 FY26 (first half of FY26) increased by 16.05% to ₹450.32 crore from ₹388.03 crore in H1 FY25, while net profit increased by 23.63% to ₹37.88 crore. The EBITDA of the company grew 22.7% to ₹86.89 crore, led by operational efficiencies and a better product mix in segments.

Segmental Highlights

The pharma-packaging business experienced solid momentum, with quarterly sales rising 45% sequentially to ₹10.81 crore from ₹7.42 crore in Q1 FY26. The company has seen more than 50% capacity utilization in the first year of operation and intends to expand further by Q3 FY26. The food & FMCG packaging business saw 34.9% volume growth, aided by an expanded product portfolio and resilience in demand amid a shorter monsoon season. The packaging of paints business grew 12.3%, as lubricant packaging reduced 9.8%, albeit offsetting by growth in other segments.

Capacity Enlargement and Strategic Initiatives

Mold-Tek is consistently strengthening its manufacturing footprint with a new Panipat unit likely to contribute from Q3 FY26. Capacity enlargement at Cheyyar and Panipat has been completed by the company to address rising demand from its OEM customers. It also won new business from Veedol Corporation, Rallis India, Ava Cholayil Health Care, Sri Balaji Process and Pharmaforce. The company is replacing its printing facility with next-generation in-mould label (IML) technology to facilitate lower order levels, cost savings and increased design flexibility.

Management Outlook

Chairman & Managing Director J. Lakshmana Rao expressed that the pharma packaging would be a growth driver and profitability driver over the next few years. He underscored that the company’s innovation, quality and customer-centric approach have well-positioned it to leverage future opportunities in the high-value pharma packaging space.

Established in 1986 and having its headquarters in Hyderabad, Mold-Tek Packaging Ltd is a prominent producer of injection-moulded rigid plastic packaging of paints, lubricants, food, FMCG and pharma segments. It has 12 units of production located throughout India with a capacity of more than 55,000 tonnes per year and is listed on BSE and NSE.

Market Performance

The shares of Mold-Tek Packaging closed at ₹722.50 on October 29, 2025, down 8.38% (₹66.10) from the previous session’s close. The stock had a 52-week range of about ₹410 to ₹892.90, indicating broad market volatility. The market capitalisation of the company is quoted at around ₹2,466 crore with a price-to-earnings ratio of about 37x.

REF: https://nsearchives.nseindia.com/corporate/MOLDTKPAC_29102025145916_SE_Intimation.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations